LDHA and breast carcinoma: LLL12 treatment resulted in a decrease in the ALDH+ subpopulation in MDA-MB-231, SUM159, and SK-BR3 cancer cells (Figure 3A), suggesting that this subpopulation of breast cancer stem-like cells is more sensitive to LLL12-mediated inhibition than is the bulk cell population.